In adults with MI and LVEF >40% after invasive care, b-blocker therapy did not reduce a composite adverse outcome at a median 3.7 y
- Orly Leiva
- , Islam Y. Elgendy
Research output: Contribution to journal › Comment/debate
Research output: Contribution to journal › Comment/debate